BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18528189)

  • 1. Technical note: identifying the prostate cancer 'superscan' by quantitative skeletal scintigraphy.
    Hawkins T; Halewood MM
    Nucl Med Commun; 2008 Jul; 29(7):654-9. PubMed ID: 18528189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a computer-aided diagnostic scheme for detection of interval changes in successive whole-body bone scans.
    Shiraishi J; Li Q; Appelbaum D; Pu Y; Doi K
    Med Phys; 2007 Jan; 34(1):25-36. PubMed ID: 17278486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of superscan on bone scintigraphy: A systematic review.
    Kovacsne A; Kozon I; Bentestuen M; Zacho HD
    Clin Physiol Funct Imaging; 2023 Sep; 43(5):297-304. PubMed ID: 37070619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer-assisted interpretation of planar whole-body bone scans.
    Sadik M; Hamadeh I; Nordblom P; Suurkula M; Höglund P; Ohlsson M; Edenbrandt L
    J Nucl Med; 2008 Dec; 49(12):1958-65. PubMed ID: 18997038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of computer-aided diagnosis system for bone scans: a retrospective analysis in 406 patients.
    Tokuda O; Harada Y; Ohishi Y; Matsunaga N; Edenbrandt L
    Ann Nucl Med; 2014 May; 28(4):329-39. PubMed ID: 24573796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
    Anand A; Morris MJ; Kaboteh R; Båth L; Sadik M; Gjertsson P; Lomsky M; Edenbrandt L; Minarik D; Bjartell A
    J Nucl Med; 2016 Jan; 57(1):41-5. PubMed ID: 26315832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative and quantitative comparison between images obtained with filtered back projection and iterative reconstruction in prostate cancer lesions of (18)F-FDG PET.
    Etchebehere EC; Macapinlac HA; Gonen M; Humm K; Yeung HW; Akhurst T; Scher HI; Larson SM
    Q J Nucl Med; 2002 Jun; 46(2):122-30. PubMed ID: 12114875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistent Superscan and Lincoln Sign on Bone Scintigraphy.
    Kulkarni M; Soni A; Shetkar S; Amer M; Mulavekar A; Joshi P
    Clin Nucl Med; 2017 Aug; 42(8):630-632. PubMed ID: 28525460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer.
    Venkitaraman R; Cook GJ; Dearnaley DP; Parker CC; Khoo V; Eeles R; Huddart RA; Horwich A; Sohaib SA
    J Med Imaging Radiat Oncol; 2009 Jun; 53(3):241-7. PubMed ID: 19624290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99Tc(m)(V)DMSA scintigraphy in skeletal metastases and superscans arising from various malignancies: diagnosis, treatment monitoring and therapeutic implications.
    Basu S; Nair N; Awasare S; Tiwari BP; Asopa R; Nair C
    Br J Radiol; 2004 Apr; 77(916):347-61. PubMed ID: 15107330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc bone scintigraphy superscans: a review.
    Buckley O; O'Keeffe S; Geoghegan T; Lyburn ID; Munk PL; Worsley D; Torreggiani WC
    Nucl Med Commun; 2007 Jul; 28(7):521-7. PubMed ID: 17538392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone tumor segmentation on bone scans using context information and random forests.
    Chu G; Lo P; Ramakrishna B; Kim H; Morris D; Goldin J; Brown M
    Med Image Comput Comput Assist Interv; 2014; 17(Pt 1):601-8. PubMed ID: 25333168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of computer-assisted analysis of skeletal lesions for the staging of prostate cancer.
    Petersen LJ; Mortensen JC; Bertelsen H; Zacho HD
    BMC Med Imaging; 2017 Jul; 17(1):40. PubMed ID: 28693433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study to evaluate the intra-individual reproducibility of bone scans for quantitative assessment in patients with metastatic prostate cancer.
    Reza M; Kaboteh R; Sadik M; Bjartell A; Wollmer P; Trägårdh E
    BMC Med Imaging; 2018 May; 18(1):8. PubMed ID: 29728144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenetic differentiation of the bone superscan using bone marrow scintigraphy].
    Weckesser M; Müller-Mattheis VG; Vosberg H; Müller-Gärtner HW
    Nuklearmedizin; 1998 Jun; 37(4):156-8. PubMed ID: 9650218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of bone metastasis of prostate cancer - comparison of whole-body MRI and bone scintigraphy].
    Ketelsen D; Röthke M; Aschoff P; Merseburger AS; Lichy MP; Reimold M; Claussen CD; Schlemmer HP
    Rofo; 2008 Aug; 180(8):746-52. PubMed ID: 18512192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of the superscan in prostatic bone scintigraphy.
    Constable AR; Cranage RW
    Br J Radiol; 1981 Feb; 54(638):122-5. PubMed ID: 7459549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative bone metastases analysis based on image segmentation.
    Erdi YE; Humm JL; Imbriaco M; Yeung H; Larson SM
    J Nucl Med; 1997 Sep; 38(9):1401-6. PubMed ID: 9293797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiologic diagnosis of bone metastases recurrence in patients with prostate cancer treated strontium-89].
    Barysheva EV; Selivanov SP; Riannel' IuE; Velichko SA; Usynin EA; Usov VIu
    Vestn Rentgenol Radiol; 1999; (5):32-6. PubMed ID: 12717923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.
    Kwee SA; Wei H; Sesterhenn I; Yun D; Coel MN
    J Nucl Med; 2006 Feb; 47(2):262-9. PubMed ID: 16455632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.